Live from the NIH registry
Studies recruiting near Champaign right now
Top 25 of 170 recruiting studies, sorted by proximity — each links to its official registry page
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 2
Interventional 81 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: National Cancer Institute (NCI)
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: NRG Oncology
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
Local Institution - 0423 — Urbana, Illinois (3.5 mi)
· Sponsor: Bristol-Myers Squibb
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm
Phase 2
Interventional 70 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: National Cancer Institute (NCI)
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
Phase 3
Interventional 228 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Phase 3
Interventional 364 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: SWOG Cancer Research Network
Pan-tumor MRD Study
Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer
N/A
Observational 1,350 participants sought
Carle Health — Urbana, Illinois (3.5 mi)
· Sponsor: Paradigm Health
Fall Prevention Among People With Spinal Cord Injury and Multiple Sclerosis Who Use Wheelchairs and Scooters
Spinal Cord Injuries (SCI), Multiple Sclerosis
N/A
Interventional 120 participants sought
Disability Participation and Quality of Life (DPQOL) Laboratory — Urbana, Illinois (3.5 mi)
· Sponsor: University of Illinois at Urbana-Champaign
Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
N/A
Interventional 600 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: NRG Oncology
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Multiple conditions
Phase 2
Interventional 98 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: NRG Oncology
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 2
Interventional 240 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: NRG Oncology
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma
Phase 2
Interventional 227 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: SWOG Cancer Research Network
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
Idiopathic Pulmonary Fibrosis (IPF)
Phase 2
Interventional 359 participants sought
Research Site — Champaign, Illinois (1.6 mi)
· Sponsor: AstraZeneca
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: SWOG Cancer Research Network
Alcohol and the Social Brain: An Alcohol-Administration Hyperscanning Study Employing a Within-Subject Design
Alcohol Drinking, Alcohol Use Disorder (AUD)
N/A
Interventional 200 participants sought
University of Illinois at Urbana Champaign — Champaign, Illinois (1.6 mi)
· Sponsor: University of Illinois at Urbana-Champaign
Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer
Locally Advanced Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma
Phase 2
Interventional 122 participants sought
Carle Cancer Center NCI Community Oncology Research Program — Urbana, Illinois (3.5 mi)
· Sponsor: Academic and Community Cancer Research United
Maternal Mindfulness: Depression and Postpartum Pain
Depression, Unipolar, Pain, Postoperative
N/A
Interventional 75 participants sought
University of Illinois Urbana-Champaign — Champaign, Illinois (1.6 mi)
· Sponsor: University of Illinois at Urbana-Champaign
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: National Cancer Institute (NCI)
Vitamin D for Prostate Endocrine Therapy
Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8
Phase 3
Interventional 240 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: University of Rochester
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Locally Advanced Cervical Adenocarcinoma, Locally Advanced Cervical Adenosquamous Carcinoma
Phase 3
Interventional 336 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: National Cancer Institute (NCI)
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Advanced Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma
Phase 2
Interventional 46 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: National Cancer Institute (NCI)
An Individualized-health eLibrary App for People With Multiple Sclerosis
Multiple Sclerosis
N/A
Interventional 60 participants sought
University of Illinois Urbana-Champaign — Champaign, Illinois (1.6 mi)
· Sponsor: University of Illinois at Urbana-Champaign
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma
N/A
Observational 800 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: University of Rochester
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Carle Cancer Center — Urbana, Illinois (3.5 mi)
· Sponsor: National Cancer Institute (NCI)
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Endometrial Cancer, Malignant Solid Tumour
Phase 3
Interventional 800 participants sought
Research Site — Urbana, Illinois (3.5 mi)
· Sponsor: AstraZeneca